Xinhua News Agency pointed out that the important meeting held on the 9th analyzed and studied the economic work in 2025, in which the expression of monetary policy attracted people's attention. After a lapse of more than 10 years, the change of monetary policy orientation to "moderately loose" once again reflects the supportive monetary policy stance and sends a positive signal, which will strongly boost the confidence of all parties and help China's economy recover.True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.
Shanghai builds a merger and reorganization head company, and Ning Wang magnifies the move. The bull market still needs to be believed.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;
Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;Wentai Technology: Shareholders plan to reduce their holdings by no more than 2%;
Strategy guide 12-13
Strategy guide
12-13
Strategy guide